These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 30350826

  • 21. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME, Kasiakou SK.
    Clin Infect Dis; 2005 May 01; 40(9):1333-41. PubMed ID: 15825037
    [Abstract] [Full Text] [Related]

  • 22. Multidrug-resistant Gram-negative bacteria: how to treat and for how long.
    Giamarellou H.
    Int J Antimicrob Agents; 2010 Dec 01; 36 Suppl 2():S50-4. PubMed ID: 21129924
    [Abstract] [Full Text] [Related]

  • 23. Polymyxin Resistance Mechanisms: From Intrinsic Resistance to Mcr Genes.
    Meletis G, Skoura L.
    Recent Pat Antiinfect Drug Discov; 2018 Dec 01; 13(3):198-206. PubMed ID: 30474535
    [Abstract] [Full Text] [Related]

  • 24. Polymyxin B versus colistin: an update.
    Cai Y, Lee W, Kwa AL.
    Expert Rev Anti Infect Ther; 2015 Dec 01; 13(12):1481-97. PubMed ID: 26488563
    [Abstract] [Full Text] [Related]

  • 25. Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB.
    Liu D, Jie F, Ding Y, Qu H, Chen D, Huang J.
    J Infect Dev Ctries; 2024 Jul 29; 18(7):1050-1057. PubMed ID: 39078788
    [Abstract] [Full Text] [Related]

  • 26. Rescuing the Last-Line Polymyxins: Achievements and Challenges.
    Nang SC, Azad MAK, Velkov T, Zhou QT, Li J.
    Pharmacol Rev; 2021 Apr 29; 73(2):679-728. PubMed ID: 33627412
    [Abstract] [Full Text] [Related]

  • 27. History, Chemistry and Antibacterial Spectrum.
    Velkov T, Thompson PE, Azad MAK, Roberts KD, Bergen PJ.
    Adv Exp Med Biol; 2019 Apr 29; 1145():15-36. PubMed ID: 31364069
    [Abstract] [Full Text] [Related]

  • 28. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS, Karatza DC.
    Expert Rev Anti Infect Ther; 2010 Sep 29; 8(9):1009-17. PubMed ID: 20818945
    [Abstract] [Full Text] [Related]

  • 29. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS, Rhomberg PR, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2015 Dec 29; 83(4):379-81. PubMed ID: 26415906
    [Abstract] [Full Text] [Related]

  • 30. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D, Zhang J, Liu HX, Zhu YG, Qu JM.
    Int J Antimicrob Agents; 2015 Dec 29; 46(6):603-9. PubMed ID: 26607337
    [Abstract] [Full Text] [Related]

  • 31. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.
    Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL.
    Lancet Infect Dis; 2006 Sep 29; 6(9):589-601. PubMed ID: 16931410
    [Abstract] [Full Text] [Related]

  • 32. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
    Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, Giacobbe DR, Viscoli C, Giamarellou H, Karaiskos I, Kaye D, Mouton JW, Tam VH, Thamlikitkul V, Wunderink RG, Li J, Nation RL, Kaye KS.
    Pharmacotherapy; 2019 Jan 29; 39(1):10-39. PubMed ID: 30710469
    [Abstract] [Full Text] [Related]

  • 33. Colistin, mechanisms and prevalence of resistance.
    Bialvaei AZ, Samadi Kafil H.
    Curr Med Res Opin; 2015 Apr 29; 31(4):707-21. PubMed ID: 25697677
    [Abstract] [Full Text] [Related]

  • 34. New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin.
    Vaara M.
    Med Res Rev; 2018 Sep 29; 38(5):1661-1673. PubMed ID: 29485690
    [Abstract] [Full Text] [Related]

  • 35. Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).
    El-Sayed Ahmed MAE, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB.
    Emerg Microbes Infect; 2020 Dec 29; 9(1):868-885. PubMed ID: 32284036
    [Abstract] [Full Text] [Related]

  • 36. The use of polymyxins to treat carbapenem resistant infections in neonates and children.
    Thomas R, Velaphi S, Ellis S, Walker AS, Standing JF, Heath P, Sharland M, Dona' D.
    Expert Opin Pharmacother; 2019 Mar 29; 20(4):415-422. PubMed ID: 30576264
    [Abstract] [Full Text] [Related]

  • 37. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA, Caruso P, Parris AR, Dizon R, Kopec R, Sharma S, Mayer S, Ghitan M, Chapnick EK.
    Ann Pharmacother; 2008 Sep 29; 42(9):1177-87. PubMed ID: 18664609
    [Abstract] [Full Text] [Related]

  • 38. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC, Reis AO, Jones RN.
    J Clin Microbiol; 2001 Jan 29; 39(1):183-90. PubMed ID: 11136768
    [Abstract] [Full Text] [Related]

  • 39. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J, Shah N, Kelly P, Babu E, Backer M, Rosas-Garcia G, Salamera J, George A, Bratu S, Landman D.
    Microb Drug Resist; 2012 Apr 29; 18(2):132-6. PubMed ID: 22196342
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME, Furuya EY, Hay CM, Pancholi P, Della-Latta P, Hammer SM, Kubin CJ.
    J Antimicrob Chemother; 2004 Aug 29; 54(2):566-9. PubMed ID: 15269195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.